Abstract
BCR-ABL1 is in the center of chronic myeloid leukemia (CML) pathology, diagnosis and treatment, as confirmed by the success of tyrosine kinase inhibit......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
